The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
23ANDME HOLDING CO CLASS A COM 90138Q108   17,925,464 10,243,122 SH   SOLE   10,243,122 0 0
ALECTOR INC COM 014442107   5,895,173 980,894 SH   SOLE   980,894 0 0
FOGHORN THERAPEUTICS INC COM 344174107   11,079,277 1,573,761 SH   SOLE   1,573,761 0 0
ISHARES TR MSCI INDIA ETF 46429B598   105,978,793 2,425,144 SH   SOLE   2,425,144 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105   1,933,886 746,674 SH   SOLE   746,674 0 0
ORIC PHARMACEUTICALS INC COM 68622P109   5,800,988 747,550 SH   SOLE   747,550 0 0
PMV PHARMACEUTICALS INC COM 69353Y103   15,933,215 2,545,242 SH   SOLE   2,545,242 0 0
RAPT THERAPEUTICS INC COM 75382E109   10,682,057 571,233 SH   SOLE   571,233 0 0
SPDR GOLD TR GOLD SHS 78463V107   98,939,850 555,000 SH   SOLE   555,000 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103   109,157,700 246,250 SH   SOLE   246,250 0 0
SURROZEN INC COM 86889P109   441,630 802,963 SH   SOLE   802,963 0 0
TENAYA THERAPEUTICS INC COM 87990A106   5,375,188 915,705 SH   SOLE   915,705 0 0